Alaunos Therapeutics (TCRT) Live Share Price, Invest From India

Alaunos Therapeutics Stock Performance

as on September 30, 2026 at 6:57 am IST

Day's Low
Day's High
$0.96
Day's Price Range
$1.05
$0.96
0.02%
Downside
9.35%
Upside
52 Week's Low
52 Week's High
$0.97
52-Week Price Range
$4.59
$0.96
-0.94%
Downside
378.03%
Upside

Alaunos Therapeutics share price movements today

Previous Close: $1.02
Open: $1.02
Volume: 193.9K
Market Cap: $2.8M
Day's Low - High: $0.96 - $1.05
52 Week Low - High: $0.97 - $4.59

Alaunos Therapeutics Historical Returns

1 Month Return: -36.45 %
3 Month Return: -56.96 %
1 Year Return: -59.07 %
3 Year Return: -94.84 %
5 Year Return: 0 %

Alaunos Therapeutics Stock Fundamentals & Key Indicators

Check Alaunos Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.8M

EPS (TTM)

-1.95

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.56

Industry PE ratio

-2.66

PEG Ratio

-0.02

EBITDA

-4.0M

Revenue (TTM)

3.0K

Profit Margin

-28133.33%

Return On Equity TTM

-232.60%

Alaunos Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alaunos Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Alaunos Therapeutics	Hold	$2.8M	NA	-0.56	-28133.33%	0.00%
Revolution Medicines	StrongBuy	$43.9B	628.83%	-23.13	0.00%	0.00%
Moderna	Neutral	$79.4B	-47.93%	-24.92	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$133.4B	189.75%	30.38	86.04%	0.00%
Regeneron	Buy	$81.1B	23.99%	18.82	84.86%	0.47%

Stock Returns calculator for Alaunos Therapeutics Stock including INR - Dollar returns

The Alaunos Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Alaunos Therapeutics investment value today

Current value as on today

₹41,692

Returns

-₹58,308

(-58.31%)

Returns from Alaunos Therapeutics Stock

-₹61,469 (-61.47%)

Dollar Impact

₹3,161 (+3.16%)

Analyst Recommendation on Alaunos Therapeutics Stock

Based on 6 analysts

HOLD

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'HOLD' rating for Alaunos Therapeutics. Average target price of $1.75

Alaunos Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Alaunos Therapeutics.

What analysts predicted

45.13%UPSIDE

Target Price

$1.75

Current Price

$0.9602

Analyzed by

6 Analysts

Target

$1.75

Alaunos Therapeutics target price $1.75, a slight upside of 45.13% compared to current price of $0.9602. According to 6 analysts rating.

Indian Investors' Interest in Alaunos Therapeutics Stock

Search interest for Alaunos Therapeutics Stock has increased by 1796% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 31, 2026 to September 30, 2026

Change:1796% versus previous 30 day period

Alaunos Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	0	0	-	0	0	-	-	0	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-1	-1	-1	0	-1	-1	-1	0	-1	0
EBITDA	-1	-1	-1	0	-1	-1	-1	0	0	0
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	-	0	-	0	-	0	0	0
Income Before Tax	-1	-1	-1	0	-1	-1	-1	0	-1	0
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-1	-1	-1	0	-1	-1	-1	0	-1	0
Net Profit Margin	-100.00%	-4400.00%	0.00%	100.00%	-17250.00%	0.00%	0.00%	-11933.33%	0.00%	0.00%

Alaunos Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	6	0	-	-	0	2	0	0	0
Gross Profit	6	0	0	-1	-46	-19	-4	0	-1
Operating Income	-53	-53	-57	-80	-77	-35	-34	-4	-4
EBITDA	-53	-53	-117	-78	-74	-31	-30	-4	-4
Interest Expense	0	-	-	-	1	3	1	-	-
Depreciation	0	0	0	1	2	2	2	0	0
Income Before Tax	-54	-53	-117	-79	-78	-37	-35	-4	-4
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	-54	-53	-117	-79	-78	-37	-35	-4	-4
Net Profit Margin	100.00%	100.00%	0.00%	0.00%	100.00%	100.00%	-95960.00%	100.00%	-27160.00%

Alaunos Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-1	-1	-1	0	-1	-1	-1	0	-1	0
Operating Cash Flow	-1	-1	0	0	0	0	0	0	-1	0
Investing Cash Flow	-	-	-	-	-	-	0	0	-	-
Financing Cash Flow	-	-	-	-	-	3	-	-	-	0
Change in Cash	-1	-1	0	0	0	2	0	0	-1	0

Alaunos Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-54	-53	-117	-79	-78	-37	-35	-4	-4
Operating Cash Flow	-54	-49	-40	-57	-61	-29	-30	-4	-2
Investing Cash Flow	0	0	0	-9	-3	0	1	-	0
Financing Cash Flow	45	40	59	102	25	6	-18	-	3
Change in Cash	-10	-9	18	35	-39	-23	-46	-4	0

Global Institutional Holdings in Alaunos Therapeutics

Check out the Institutions with significant holdings in Alaunos Therapeutics.

Funds	Holdings
Victory Portfolios III	0.83%
Fidelity Concord Street Trust	0.62%
VANGUARD INDEX FUNDS	0.48%
Vanguard	0.48%

Insights on Alaunos Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -1.00M → -952.0K (in $), with an average increase of 5.7% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 2.0K → 3.0K (in $), with an average increase of 33.3% per quarter
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 678.8% return, outperforming this stock by 737.9%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 91.0% return, outperforming this stock by 185.8%
NEGATIVE IMPACT
Price Dip
In the last 7 days, TCRT stock has moved down by -19.7%

About Alaunos Therapeutics

Alaunos Therapeutics, Inc. is an oncology company in the clinical trial phase, specializing in the creation of adoptive T-cell receptor (TCR) engineered therapies. Their pipeline includes a TCR Library, currently undergoing Phase I/II clinical trials, which comprises ten T-cell receptors designed to target mutated KRAS, TP53, and EGFR in various cancers such as non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers. Additionally, they are advancing hunTR, a platform focused on human neoantigen T-cell receptors, and mbIL-15, intended for solid tumor treatment. The company maintains strategic collaborations, including a licensing agreement with PGEN Therapeutics, Inc., a research and development partnership with The University of Texas MD Anderson Cancer Center, and both a patent licensing and R&D agreement with the National Cancer Institute. Previously known as ZIOPHARM Oncology, Inc., the company adopted its current name, Alaunos Therapeutics, Inc., in January 2022. Its headquarters are located in Houston, Texas.

Organisation	Alaunos Therapeutics
Headquarters	501 E. Las Olas Blvd., Fort Lauderdale, FL, 33301, US
Industry	Biotechnology
CEO	Holger Weis

Key Management of Alaunos Therapeutics

Name	Title
Mr. Holger Weis CPA	Chairman of the Board & CEO
Mr. Ferdinand Groenewald	Vice President of Finance & Corporate Secretary

FAQs

What is Alaunos Therapeutics share price today?

Alaunos Therapeutics share price today is $0.96 as on September 30, 2026 at 1:27 am IST at the close of the market. Alaunos Therapeutics share today touched a day high of $1.05 and a low of $0.96.

What is the 52 week high and 52 week low for Alaunos Therapeutics share?

Alaunos Therapeutics share touched a 52 week high of $4.59 on October 9, 2025 and a 52 week low of $0.97 on September 28, 2026. Alaunos Therapeutics stock price today i.e. September 30, 2026 at 1:27 am IST is closed at $0.96,which is 79.08% down from its 52 week high and -0.93% up from its 52 week low.

What is Alaunos Therapeutics's market capitalisation today?

Alaunos Therapeutics market capitalisation is $0.00T as on September 30, 2026 at 1:27 am IST.

How to invest in Alaunos Therapeutics Stock (TCRT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Alaunos Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Alaunos Therapeutics Stock (TCRT) from India?

Indian investors can start investing in Alaunos Therapeutics (TCRT) shares with as little as ₹95.980003356934 or $1 (as of September 30, 2026 at 4:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹959.80 in Alaunos Therapeutics stock (as per the Rupee-Dollar exchange rate as on September 30, 2026 at 4:43 am IST). Based on Alaunos Therapeutics share’s latest price of $0.96 as on September 30, 2026 at 1:27 am IST, you will get 10.4145 shares of Alaunos Therapeutics. Learn more about fractional shares .